The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
But experts say there may be a number of opportunities for lab-grown meat under a second Trump administration. Industry ...
With Trump’s federal freeze pausing health updates from agencies like CDC, and FDA, Georgia residents will have to look elsewhere for important information.
Robert F. Kennedy Jr. faced about 3.5 hours of questioning on topics including his past comments on vaccines and abortion ...
It marks one of Kennedy’s clearest public statements on abortion since being nominated to lead the nation’s health department ...
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...